Approximately a quarter of individuals with primary sclerosing cholangitis experience moderate-severe pruritus.
Weiss, Chief Executive Officer and Chairman of TG Therapeutics stated, “We are pleased to share data at this year’s ACTRIMS annual meeting, including updates from the ENABLE real world study ...
Noninvasive imaging tests may help identify at-risk metabolic dysfunction-associated steatohepatitis, with a FibroScan-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results